(Q48488904)
Statements
Selegiline transdermal system for the treatment of major depressive disorder: an 8-week, double-blind, placebo-controlled, flexible-dose titration trial (English)
Alan D Feiger
Karl Rickels
Moira A Rynn
Dan L Zimbroff
Donald S Robinson
1 September 2006